AGRINFO AGRINFO logo

THE LATEST ON EU AGRI-FOOD POLICIES IMPACTING LOW- AND MIDDLE-INCOME COUNTRIES

2023/905

Rules on prohibited antimicrobials in imported animal products

  • Animal health
  • Antimicrobial resistance

Summary

Regulation 2023/905 applies restrictions on the use of antimicrobials to live animals and animal products imported into the EU. It bans the use of antimicrobials as growth promoters or to increase yield, and the use of certain antimicrobials reserved for human treatments. This extends the restrictions that apply to animals reared in the EU to include imported live animals and animal products.

In order to export such products to the EU, countries will have to be included in the official list of authorised exporting countries (confirming they are compliant with the new antimicrobial rules) by 3 September 2026, and must use the updated official certificates that have an attestation of compliance signed by their competent authorities.

EU bans use in food-producing animals of antimicrobials to promote growth or increase yield, and of certain antimicrobials reserved for human treatments

Commission Delegated Regulation (EU) 2023/905 of 27 February 2023 supplementing Regulation (EU) 2019/6 of the European Parliament and of the Council as regards the application of the prohibition of use of certain antimicrobial medicinal products in animals or products of animal origin exported from third countries into the Union

Update

Regulation 2023/905 applies restrictions on the use of antimicrobials to live animals and animal products imported into the EU. It bans the use of antimicrobials as growth promoters or to increase yield, and the use of certain antimicrobials reserved for human treatments. This extends the restrictions that apply to animals reared in the EU to include imported live animals and animal products.

In order to export such products to the EU, countries will have to be included in the official list of authorised exporting countries (confirming they are compliant with the new antimicrobial rules) by 3 September 2026, and must use the updated official certificates that have an attestation of compliance signed by their competent authorities.

Impacted Products

Livestock and animal products for human consumption.

Exceptions are:

- gelatine, collagen, highly refined products, composite products, wild animals, insects, frogs, snails, and reptiles

- animals and food in transit not placed on the EU market

- animals or animal products not intended for human consumption

- samples for product analysis and quality testing not placed on the market.

What is changing?

Under Regulation 2022/1255, certain antimicrobials are reserved for human treatment in the EU (and thus are prohibited from being used in food-producing animals), and Regulation 2019/6 (Art. 107) bans the use of antimicrobials for growth promotion in the EU. Non-EU countries (2019/6, Art. 118) must:

  • show evidence of compliance with the prohibition on antimicrobials; compliant countries will be placed on the list of authorised exporting countries
  • confirm compliance by signing a new specific attestation for each consignment, which must be added to the official certificates already required for animal product exports.

Regulation 2023/905 extends these rules to animals or products of animal origin imported into the EU. The EU is reinforcing these rules by establishing a list of authorised countries that have demonstrated that they meet EU requirements, and providing revised Model health certificates that include a specific attestation on antimicrobials.

The new rules will not apply to products in transit in the EU, or to gelatine, collagen, highly refined products, composite products, wild animals, insects, frogs, snails, or reptiles.

Why?

Antimicrobial (antibiotic) resistance is viewed as a major threat to global health. The EU seeks to ensure prudent and responsible use of antimicrobials in animals. It prohibits the use in animals of certain antimicrobials that are used to treat humans, to ensure their continued effectiveness. Antimicrobials cannot be used either as growth promoters or to increase yield.

Timeline

The new rules apply from 3 September 2026 (24 months after Regulation 2024/399 laying down the revised Model health certificates enters into application).

What are the major implications for exporting countries?

Only countries that can guarantee exported animal products meet the EU’s antimicrobial requirements will be able to continue exporting animal products to the EU. From 3 September 2026, non-EU country authorities will need to be on the list of authorised exporting countries and must certify each consignment of animal products exported to the EU.

Recommended Actions

Non-EU countries exporting livestock and animal products to the EU will have to put in place a system that can guarantee prohibited antimicrobials are not used in goods exported to the EU market during the whole lifetime of the animals.

Particular attention must be paid to products that have a long cycle of production (beef, casings, processed products, etc.). To be able to export such products to the EU from 3 September 2026, the guarantees must be in place from the birth of the food-producing animals, which may mean, for example, a period of 2 years or more prior to export.

In each country, competent authorities will have to assess what steps are required to comply with Regulation 2023/905. Coordination with representatives of the livestock and animal products sector will be needed, and potentially the adoption of national legislation or adaptation of control systems.

A forthcoming draft Implementing Regulation listing authorised non-EU countries will be notified to the World Trade Organization. In the meantime, any questions can be emailed to agrinfo@colead.link.

Background

To fight antimicrobial resistance and combat its global spread, Regulation 2019/6, Art. 118(1) established that the following provisions are also to be applied to operators from non-EU countries exporting animals and certain animal products for human consumption to the European Union:

  • the prohibition of using antimicrobials to promote growth and increase yield
  • the prohibition of using antimicrobials reserved for the treatment of specific infections in humans, as listed in the Annex of Implementing Regulation 2022/1255 (see List of antimicrobials reserved for treatment of certain infections in humans); the criteria for which antimicrobials are reserved for human use are established in Regulation (EU) 2021/1760.

The list of non-EU countries, and the adaptation of the official certificates, will be based on the Official Controls Regulation 2017/625 (Arts. 126 and 127).

Resources

European Commission (2024) State of play concerning the implementation of Commission Delegated Regulation (EU) 2023/905. Powerpoint presentation, 6 March.

European Commission: Regulation (EU) 2019/6 – Delegated Acts: “Detailed rules regarding animals or products of animal origin imported into the Union (Article 118 (2))”

Regulation 2024/399 as regards model certificates for the entry into the Union of consignments of certain products of animal origin and certain categories of animals

Regulation (EU) 2022/1255 designating antimicrobials or groups of antimicrobials reserved for treatment of certain infections in humans

Regulation (EU) 2021/1760 establishing the criteria for the designation of antimicrobials to be reserved for the treatment of certain infections in humans

Regulation 2019/6 on veterinary medicinal products

Sources

Regulation 2023/905 as regards the application of the prohibition of use of certain antimicrobial medicinal products in animals or products of animal origin exported from third countries into the Union

Disclaimer: Under no circumstances shall COLEAD be liable for any loss, damage, liability or expense incurred or suffered that is claimed to have resulted from the use of information available on this website or any link to external sites. The use of the website is at the user’s sole risk and responsibility. This information platform was created and maintained with the financial support of the European Union. Its contents do not, however, reflect the views of the European Union.

EU bans use in food-producing animals of antimicrobials to promote growth or increase yield, and of certain antimicrobials reserved for human treatments

Regulation 2023/905 as regards the application of the prohibition of use of certain antimicrobial medicinal products in animals or products of animal origin exported from third countries into the Union

What is changing and why?

Resistance to antimicrobial medicines (or antibiotics) is viewed as a major threat to global health. The EU seeks to ensure prudent and responsible use of antimicrobials in animals. Rules that were already in place for animals reared in the EU are now extended to imported animals and animal products:

  • antimicrobials that are used to treat humans must not be used in animals (Regulation 2022/1255)
  • antimicrobials cannot be used either as growth promoters or to increase yield (Regulation 2019/6).

From 3 September 2026, non-EU countries wishing to export animals or animal products to the EU will need to be on the list of authorised exporting countries recognised as meeting EU requirements, and their competent authorities must certify that each consignment of animal products exported to the EU meets those requirements.

Actions

Each country must decide what actions are needed to comply with Regulation 2023/905. This will involve working with people in the livestock and animal products industry, and possibly creating new national laws or updating control systems.

Special attention is needed for products with long production times, such as beef, casings, and processed items. To export these to the EU after 3 September 2026, the required guarantees must cover the animals’ entire lifetime. For example, this could mean starting the process at least 2 years before exporting.

Timeline

The new rules apply from 3 September 2026.

Disclaimer: Under no circumstances shall COLEAD be liable for any loss, damage, liability or expense incurred or suffered that is claimed to have resulted from the use of information available on this website or any link to external sites. The use of the website is at the user’s sole risk and responsibility. This information platform was created and maintained with the financial support of the European Union. Its contents do not, however, reflect the views of the European Union.